nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

01.08.2014

Hemostasis, cancer, and ABO blood group: the most recent evidence of association

verfasst von: Giancarlo Maria Liumbruno, Massimo Franchini

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Human ABO blood group antigens are expressed on the surface of red blood cells and a variety of human cells and tissues. However, an increasingly number of studies show that the ABO blood group, in addition to its fundamental role in transfusion medicine and in several other disciplines, has a causal role in predisposing to several human diseases, including hemostasis and neoplastic disorders, which will be the focus of this narrative review.

Preston AE, Barr A (1964) The plasma concentration of factor VIII in the normal population. Br J Haematol 10:238–245PubMedCrossRef

Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V (2001) Influence of ABO blood groups on primary hemostasis. Transfusion 2001:56–60CrossRef

O’Donnell JS, Lasffan MA (2001) The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 11:343–351PubMedCrossRef

Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691–1695PubMed

Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–155PubMedCrossRef

Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the atherosclerosis risk in communities (ARIC) Study. Circulation 96:1102–1108PubMedCrossRef

Whincup PH, Danesh J, Walker M et al (2002) Von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 23:1764–1770PubMedCrossRef

Franchini M, Capra F, Targher G, Montagnana M, Lippi G (2007) Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 5:14PubMedCentralPubMedCrossRef

Franchini M, Favaloro EJ, Targher G, Lippi G (2012) ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 49:137–149PubMedCrossRef

10.

Franchini M, Liumbruno GM (2013) ABO blood group: old dogma, new perspectives. Clin Chem Lab Med 51:1545–1553PubMed

11.

Franchini M, Makris M (2013) Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus 11:164–165PubMedCentralPubMed

12.

Dick W, Schneider W, Brockmuller K, Mayer W (1963) Interrelations of thrombo-embolic diseases and blood group distribution. Thromb Diath Haemorrh 9:472–474

13.

Wautrecht JC, Galle C, Motte S, Dereume JP, Dramaix M (1998) The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 79:688–689PubMed

14.

Tirado I, Mateo J, Soria JM et al (2005) The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 93:468–474PubMed

15.

Ohira T, Cushman M, Tsai YM et al (2007) ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 5:1455–1461PubMedCrossRef

16.

Wu O, Bayoumi N, Vickers MA, Clark P (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 6:62–69PubMedCrossRef

17.

Dentali F, Sironi AP, Ageno W et al (2012) Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 38:535–548PubMedCrossRef

18.

He M, Wolpin B, Rexrode K et al (2012) ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 32:2314–2320PubMedCentralPubMedCrossRef

19.

Franchini M, Rossi C, Mengoli C et al (2013) ABO blood group and the risk of coronary artery disease. J Thromb Thrombolysis 36:286–287PubMedCrossRef

20.

Jukic I, Bingulac-Popovic J, Dogic V et al (2013) Evaluation of ABO blood groups as a risk factor for myocardial infarction. Blood Transfus 11:464–465PubMedCentralPubMed

21.

Hanson E, Karlsson S, Jood K, Nilsson S, Blomstrand C, Jern C (2012) No evidence for an association between ABO blood group and overall ischemic stroke or any of the major etiologic subtypes. Thromb Res 130:339–342PubMedCrossRef

22.

Williams FM, Carter AM, Hysi PG et al (2013) Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol 73:16–31PubMedCentralPubMedCrossRef

23.

Horwich L, Evans D, McConnell R, Donohoe W (1966) ABO blood groups in gastric bleeding. Gut 7:680–685PubMedCentralPubMedCrossRef

24.

Evans D, Horwich L, McConnell R, Bullen M (1968) Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer. Gut 9:319–322PubMedCentralPubMedCrossRef

25.

Berg M (1969) Influence of age and ABO blood groups in the precipitation of bleeding peptic ulcers. Gut 10:1029–1030PubMedCentralPubMedCrossRef

26.

Viskum K (1972) Long-term survival of patients with gastrointestinal hemorrhage with special reference to the ABO blood Groups. Scand J Gastroenterol 7:55–63PubMedCrossRef

27.

Reddy VM, Daniel M, Bright E, Broad SR, Moir AA (2008) Is there an association between blood group O and epistaxis? J Laryngol Otol 22:366–368

28.

Bayan K, Tuzun Y, Yilmaz S, Dursun M, Canoruc F (2009) Clarifying the relationship between ABO/Rhesus blood group antigens and upper gastrointestinal bleeding. Dig Dis Sci 54:1029–1034PubMedCrossRef

29.

Kuyvenhoven JP, Veenendaal RA, Vanderbroucke JP (1999) Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection and the ABO blood group system. Scand J Gastroenterol 34:1082–1086PubMedCrossRef

30.

Dentali F, Sironi AP, Ageno W et al (2013) Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis. Semin Thromb Hemost 39:72–82PubMedCrossRef

31.

Garcia AA, van der Heijden JF, Meijers JCM et al (2006) The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment. J Thromb Haemost 4:1418–1420PubMedCrossRef

32.

Pruissen DMO, Rosendaal FR, Gorter JW, Garcia AA, Kappelle LJ, Algra A (2007) Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin. J Neurol 254:1660–1665PubMedCrossRef

33.

Franchini M, Crestani S, Frattini F, Mengoli C, Bonfanti C (2012) Relationship between ABO blood group and bleeding complications in orally anticoagulated patients. J Thromb Haemost 10:1688–1691PubMedCrossRef

34.

Garratty G (2000) Blood groups and disease: a historical perspective. Transfus Med Rev 14:291–301PubMedCrossRef

35.

Seow LJ, Kwa SB, Teoh CK (1964) A preliminary survey of ABO blood group frequency in nasopharyngeal carcinoma in Chinese patients. Singapore Med J 4:93–95PubMed

36.

Turkoz FP, Celenkoglu G, Dogu GG (2011) Risk factors of nasopharyngeal carcinoma in Turkey—an epidemiological survey of the Anatolian Society of Medical Oncology. Asian Pac J Cancer Prev 12:3017–3021PubMed

37.

Sheng L, Sun X, Zhang L, Su D (2013) ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China. Int J Cancer 133:893–897PubMedCrossRef

38.

Joh HK, Cho E, Choueiri TK (2012) ABO blood group and risk of renal cell cancer. Cancer Epidemiol 36:528–532PubMedCentralPubMedCrossRef

39.

Kaffenberger SD, Morgan TM, Stratton KL (2012) ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. BJU Int 110:E641–E646PubMedCrossRef

40.

Xie J, Qureshi AA, Li Y, Han J (2010) ABO blood group and incidence of skin cancer. PLoS ONE 5:e11972PubMedCentralPubMedCrossRef

41.

Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS (2011) ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 128:482–486PubMedCentralPubMedCrossRef

42.

Yuzhalin AE, Kutikhin AG (2012) ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia. Asian Pac J Cancer Prev 13:5091–5096PubMedCrossRef

43.

Khalili H, Wolpin BM, Huang ES et al (2011) ABO blood group and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 20:1017–1029PubMedCentralPubMedCrossRef

44.

Lee JS, Ro JY, Sahin AA et al (1991) Expression of blood-group antigen A—a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 324:1084–1090PubMedCrossRef

45.

Oguz A, Unal D, Tasdemir A et al (2013) Lack of any association between blood groups and lung cancer, independent of histology. Asian Pac J Cancer Prev 14:453–456PubMedCrossRef

46.

Urun Y, Utkan GA, Cangir K et al (2013) Association of ABO Blood Group and Risk of Lung Cancer in a Multicenter Study in Turkey. Asian Pac J Cancer Prev 14:2801–2803PubMedCrossRef

47.

Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM (2012) ABO blood group and breast cancer incidence and survival. Int J Cancer 130:2129–2137PubMedCentralPubMedCrossRef

48.

Miao SY, Zhou W, Chen L, Wang S, Liu SA (2013) Influence of ABO blood group and Rhesus factor on breast cancer risk: a meta-analysis of 9665 breast cancer patients and 244768 controls. Asia Pac J Clin Oncol. doi:10.1111/ajco.12083 PubMed

49.

Bosetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP, Boffetta B (2012) Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog 51:3–13PubMedCrossRef

50.

Aird I, Lee DR, Roberts IA (1960) ABO blood groups and cancer of oesophagus, cancer of pancreas, and pituitary adenoma. Br Med J 1:1163–1166PubMedCentralPubMedCrossRef

51.

Macafee AL (1964) ABO blood groups and carcinoma of pancreas. Ulster Med J 33:129–131PubMedCentralPubMed

52.

Annese V, Minervini M, Gabbrielli A, Gambassi G, Manna R (1990) ABO blood groups and cancer of the pancreas. Int J Pancreatol 6:81–88PubMed

53.

Vioque J, Walker AM (1991) Pancreatic cancer and ABO blood types: a study of cases and controls. Med Clín 96:761–764

54.

Wolpin BM, Chan AT, Hartge P et al (2009) ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 101:424–431PubMedCentralPubMedCrossRef

55.

Amundadottir L, Kraft P, Stolzenberg-Solomon RZ et al (2009) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41:986–990PubMedCentralPubMedCrossRef

56.

Wolpin BM, Kraft P, Gross M et al (2010) Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 70:1015–1023PubMedCentralPubMedCrossRef

57.

Wolpin BM, Kraft P, Xu M et al (2010) Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 19:3140–3149PubMedCentralPubMedCrossRef

58.

Moran AP, Gupta A, Joshi L (2011) Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut 60:1412–1425PubMedCrossRef

59.

Rizzato D, Campa D, Pezzilli R et al (2013) ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep 29:637–644

60.

Iodice S, Maisonneu P, Botteri E, Sandri MT, Lowenfels AB (2010) ABO blood group and cancer. Eur J Cancer 46:3345–3350PubMedCrossRef

61.

Pelzer U, Klein F, Bahra M et al (2013) Blood group determinates incidence for pancreatic cancer in Germany. Front Physiol 24:118

62.

Risch HA, Lu L, Wang J et al (2013) ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. Am J Epidemiol 177:1326–1337PubMedCentralPubMedCrossRef

63.

Risch HA, Yu H, Lu L, Kidd MS (2010) ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case–control study. J Natl Cancer Inst 102:502–505PubMedCentralPubMedCrossRef

64.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef

65.

Aird I, Bentall HH, Fraser Roberts JA (1953) A relationship between cancer of stomach and the ABO blood groups. Br Med J 1:799–801PubMedCentralPubMedCrossRef

66.

Clarke CA (1961) Blood group and disease. In: Steiberg AG (ed) Progress in medical genetics. Grune and Stratton, New York, pp 81–119

67.

Garratty G (1994) Do blood groups have a biological role? In: Garratty G (ed) Immunobiology of transfusion medicine. Marcel Dekker, Inc., New York, pp 201–255

68.

Edgren G, Hjalgrim H, Rostgaard K et al (2010) Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 172:1280–1285PubMedCrossRef

69.

Wang Z, Liu L, Ji J et al (2012) ABO blood group system and gastric cancer: a case–control study and meta-analysis. Int J Mol Sci 13:13308–13321PubMedCentralPubMedCrossRef

70.

Rizzato C, Kato I, Plummer M et al (2013) Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status. Int J Cancer 133:315–322PubMedCrossRef

71.

Nakao M, Matsuo K, Ito H et al (2011) ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection. Cancer Epidemiol Biomarkers Prev 20:1665–1672PubMedCrossRef

72.

Song HR, Shin MH, Kim HN et al (2013) Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population. Gastric Cancer 16:254–260PubMedCrossRef

Titel: Hemostasis, cancer, and ABO blood group: the most recent evidence of association
verfasst von: Giancarlo Maria Liumbruno
Massimo Franchini
Publikationsdatum: 01.08.2014
Verlag: Springer US
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 2/2014
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-013-1027-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Hemostasis, cancer, and ABO blood group: the most recent evidence of association

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban

Circadian variation in the effect of intravenous thrombolysis after non-lacunar stroke

Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease

Downregulation of T-bet/GATA-3 ratio induced by IL-11 treatment is responsible for Th1/Th2 balance restoration in human immune thrombocytopenic purpura (ITP)

Portal vein thrombosis after laparoscopic splenectomy during childhood

Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin